The Fedtrade® podcast recently interviewed Adam Boltik, Program Manager for the Office of International Commerce of the State of New Hampshire Department of Business and Economic Affairs, as part of our SelectUSA Investment Summit Spotlight series. The Department of Business
In our previous articles, we reported that the Federal Circuit affirmed the district court’s decision on December 20, 2024 ordering Teva Pharmaceuticals (“Teva”) to delist certain patents related to Teva’s ProAir® HFA metered-dose inhaler from the FDA’s Orange Book, and
On Friday, February 28, 2025, the United States Patent and Trademark Office (USPTO) announced the withdrawal of the June 2022 memorandum titled “Interim Procedure for Discretionary Denials in AIA Post-Grant Proceedings with Parallel District Court Litigation,” which had been issued
The Fedtrade® podcast recently interviewed Lukas Zitz, Deputy Austrian Trade Commissioner of Advantage Austria, as part of our SelectUSA Investment Summit Spotlight series. With around 100 offices in over 70 countries, Advantage Austria provides a broad range of intelligence and
The Fedtrade® podcast recently interviewed Michel Belval, President of the Quebec Chapter of The American Chamber of Commerce in Canada (AmCham Quebec), as part of our SelectUSA Investment Summit Spotlight series. With seven chapters located across Canada, AmCham Canada is committed
For the past few months, the beneficial ownership reporting obligations under the Corporate Transparency Act (the “CTA”) have fluctuated between being required pursuant to the CTA and being halted by nationwide preliminary injunctions. However, as of February 18, 2025, all
The Fedtrade® Podcast recently interviewed Jeffrey Smith, Chief Operating Officer at Factum Global, as part of our SelectUSA Investment Summit Spotlight series. Factum Global is an international consulting firm that specializes in helping businesses and associations expand internationally. Members of Factum
The U.S. stands at a crossroads in light of rising drug prices and it is unclear what the future will hold in answer to the rising drug costs. Biologic medicines have rapidly expanded available treatment options and accounted for approximately
The Fedtrade® Podcast recently interviewed Robert Leo, a customs and international trade attorney at Meeks, Sheppard, Leo & Pillsbury LLP, a specialized law firm representing clients on customs and related international trade issues. The firm represents clients before the principal international
Introduction
On January 6, 2025, the FDA released draft guidance on using artificial intelligence (AI) in regulatory decision-making for drugs and biological products. The draft guidance – the first of its kind from the agency – aims to enhance the
